René Russo
Chief Executive Officer presso XILIO THERAPEUTICS, INC.
Patrimonio netto: 216 684 $ in data 31/03/2024
Profilo
Fondatore di Adagio Therapeutics, Inc., René Russo ricopre attualmente la posizione di presidente di Adagio Therapeutics, Inc. e di presidente, amministratore delegato e direttore di Xilio Therapeutics, Inc. Il dott. Russo è anche nel consiglio di Celsius Therapeutics, Inc. e X4 Pharmaceuticals, Inc. (ex presidente, amministratore delegato e direttore). Nella sua carriera passata la dottoressa Russo è stata direttore presso Arsanis, Inc. e vicepresidente degli affari medici globali presso Cubist Pharmaceuticals LLC. René Russo ha conseguito un dottorato e una laurea presso la Rutgers Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
XILIO THERAPEUTICS INC
0.73% | 01/01/2024 | 200 633 ( 0.73% ) | 216 684 $ | 31/03/2024 |
Posizioni attive di René Russo
| Società | Posizione | Inizio |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Chief Executive Officer | 22/05/2019 |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Director/Board Member | 01/05/2020 |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The private company is based in Waltham, MA. The CEO of the company is René Russo. | Chief Executive Officer | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
| Life Science Cares, Inc. | Director/Board Member | - |
Leyden Labs
 Leyden Labs BiotechnologyHealth Technology Leyden Labs develops preventive medicines that target respiratory viruses. The private company is based in Leiden, Netherlands. | Director/Board Member | - |
Precedenti posizioni note di René Russo
| Società | Posizione | Fine |
|---|---|---|
| INVIVYD, INC. | Founder | 01/07/2022 |
| INVIVYD, INC. | Chairman | 01/06/2022 |
| X4 PHARMACEUTICALS, INC. | Chief Executive Officer | 26/11/2018 |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formazione di René Russo
| Rutgers Business School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Health Technology |
| Life Science Cares, Inc. | |
Xilio Therapeutics LLC
Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The private company is based in Waltham, MA. The CEO of the company is René Russo. | Health Technology |
Leyden Labs
Leyden Labs BiotechnologyHealth Technology Leyden Labs develops preventive medicines that target respiratory viruses. The private company is based in Leiden, Netherlands. | Health Technology |
- Borsa valori
- Insiders
- René Russo
